Panel Orders Consolidation of Xarelto Federal Court Lawsuits
The U.S. Judicial Panel on Multidistrict Litigation (JPML) has ordered the consolidation of all federal court lawsuits filed against Johnson & Johnson’s Janssen Pharmaceuticals Inc. unit and Bayer...
View ArticleStudy Finds Risperdal, Other Antipsychotics Raise Acute Kidney Injury Risk in...
Researchers have found that the use of Risperdal and other atypical antipsychotic drugs on elderly patients may expose them to an increased risk of suffering acute kidney injury (AKI). As NPR reported...
View ArticleCourt Allows Plaintiffs to Present Birth Defects Expert in Zoloft MDL
Plaintiffs suing Pfizer over claims that its Zoloft antidepressant medication caused their children to suffer birth defects can present a key expert witness thanks to a ruling by the judge overseeing...
View ArticleFederal Judge Urges Bard to Settle Transvaginal Mesh Lawsuits
In December, a federal court judge made the “very rare” move of warning C.R. Bard Inc. that it could be facing financial ruin if it fails to settle thousands of defective transvaginal mesh lawsuits...
View ArticleJury Returns $2.3 Million Verdict in Actos Bladder Cancer Case
A jury has returned a $2.3 million verdict in favor of a former teacher who claimed that the manufacturer of the Actos diabetes drug failed to properly warn doctors about the drug’s risk of causing...
View ArticleReport: FDA Drug Monitoring System Flooded with Incomplete Reports
The U.S. Food and Drug Administration (FDA) must modernize its monitoring system to improve the quality of information it collects about dangerous drug side effects, according to a new report by the...
View ArticleWhat Did the Former FDA Chief Say About Risperdal?
Johnson & Johnson’s Janssen unit knew as far back as 2001 that Risperdal could cause breast growth in boys, the former head of the U.S. Food and Drug Administration (FDA) recently testified in the...
View ArticleFDA Warns of Possible Risk of Strokes and Heart Attacks with Low T Products
The U.S. Food and Drug Administration (FDA) has ordered manufacturers of testosterone products – or “low T” products – to change their labels to clarify the approved uses of these medications and to...
View ArticleAttention Focuses on Potential Zofran-Related Birth Defects
With “safe and effective” drugs now available to help women suffering from nausea and vomiting during pregnancy, “there is no reason for women to be exposed to a drug of unproven maternal and fetal...
View ArticleClik here to view.
FDA Warns About New Class of Diabetes Drugs
Another class of prescription drugs that are designed to control diabetes have come under fire as dangerous drugs that may be linked to potentially deadly side effects. A recent U.S. Food and Drug...
View Article
